Quality of life measurement in pancreatic cancer patients : a randomized trial of percutaneous splanchnic nerve neurolysis versus endoscopic ultrasound guide celiac plexus neurolysis S-celiac plexus neurolysis

Ratchadapisek Research Funds0 个研究点目标入组 60 人开始时间: 2022年5月12日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•1. age above 18 years
•2. Pancreatic cancer patient with numeric rating scale more than 4 from total 10 score
•3.patient can make decision to apply the study by themselves and cooperate with the protocol
•4.Patient who can follow up for 1 month after procedure

•1. Allergic to agent in study
•2.Refuse to join study
•3. gut obstruction
•3.coagulopathy or use antiplatelet or anticoagulant drug that can not control bleeding risk
•4.Pregnancy
•5.uncontrol underlying disease sush as uncontrol hypertension, heart failure
•6.uncommunicative patient
•7.severe systemic infection, local infection in procedure area
•8.patient who have pain in other area except abdominal pain
•9.Previous percutaneous splanchnic nerve neurolysis or endoscopic ultrasound guide celiac plexus neurolysis

发起方

Ratchadapisek Research Funds